Depletion of STAT6 suppresses lung cancer progression through regulating M2-macrophage polarization

C. Fu (SH, China), S. Li (SH, China)

Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Session: Lung cancer: from the bench to the bedside
Session type: Thematic Poster
Number: 2842
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Fu (SH, China), S. Li (SH, China). Depletion of STAT6 suppresses lung cancer progression through regulating M2-macrophage polarization. 2842

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Overexpression of LincR-PICALM promotes lung cancer proliferation and metastasis by miR-199a-3p suppression and cis- regulation
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019

Bile acid receptor accelerates to the lung cancer process induced by lung fibroblast-tumor cells interaction, with high activation of phosphorylated STAT3 and alteration of cytokine secretion
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020

GSK-3 inhibition suppresses lung cancer cell survival, metastasis and proliferation through down-regulation the phosphorylation sites of CAP1
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011

MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

The effect of compensatory induction of various PTEN mutants against TGFbeta-induced translocation of beta-catenin in lung cancer cells
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013

Inhibition of osteopontin modulates tumor-stimulated immune response and suppresses mesothelioma progression
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012



Late Breaking Abstract - Membrane bile acid receptor contributes to the proliferation of lung cancer cells induced by lung fibroblast-tumor cells  interaction though TLR4/NF-kB signaling pathway
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

c-Met expression induction in immune cells modulates pulmonary fibrosis progression
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020

The role of NFATc1 in T cell responses during the development of NSCLC
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017


Transcription factor FOXF1 induces cancer-associated fibroblast-like phenotype to promote lung cancer progression
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009



EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008

P2X7 receptor regulates cell survival, inflammation processes and proliferation of lung carcinoma cells
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019

Over-expression of aquaporin-5 increases migration and metastatic potential of lung cancer cells
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009


Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses tumor-specific T cell immunity
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012

A T cell-specific inhibitor of NF-kappaB and AP-1 suppresses lung fibrosis in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 101s
Year: 2004